Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://aus.social/users/DenisCOVIDinfoguy/statuses/116705903433056303">Denis - The COVID info guy - (deniscovidinfoguy@aus.social)'s status on Sunday, 07-Jun-2026 09:41:02 JST</a><a href="https://aus.social/@DenisCOVIDinfoguy" title="deniscovidinfoguy@aus.social"><img src="https://gnusocial.jp/avatar/147606-48-20250924104446.webp" width="48" height="48" alt="Denis - The COVID info guy -" style="position: absolute; left: 0; top: 0;">Denis - The COVID info guy -</a></section><article><p>New Immune System Enhancer Extends COVID-19 Vaccine Protection In Animal Models.</p><p>"Pairing COVID-19 mRNA vaccines with an immune system enhancer, known as an adjuvant, could make the vaccines more effective and longer-lasting, according to new research led by Harvard Medical School researchers at Boston Children’s Hospital."</p><p>Source: <a href="https://hms.harvard.edu/news/new-immune-system-enhancer-extends-covid-19-vaccine-protection-animal-models" rel="nofollow">https://hms.harvard.edu/news/new-immune-system-enhancer-extends-covid-19-vaccine-protection-animal-models</a></p><p>Study: <a href="https://www.nature.com/articles/s41590-026-02517-3" rel="nofollow">https://www.nature.com/articles/s41590-026-02517-3</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/6457441#notice-12712282">In conversation</a><time datetime="2026-06-07T09:41:02+09:00" title="Sunday, 07-Jun-2026 09:41:02 JST">about a month ago</time> <span>from <span><a href="https://aus.social/@DenisCOVIDinfoguy/116705903433056303" rel="external" title="Sent from aus.social via ActivityPub">aus.social</a></span></span><a href="https://aus.social/@DenisCOVIDinfoguy/116705903433056303">permalink</a><h4>Attachments</h4><ol><li><label><a rel="external" href="https://gnusocial.jp/attachment/6150727">An image showing a research article webpage from Harvard Medical School, dated June 5, 2026.
Layout and Content
•	Header: Displays the Harvard Medical School crest and logo at the top centre.
•	Headline: Large, bold white text on a dark grey background reads: "New Immune System Enhancer Extends COVID-19 Vaccine Protection In Animal Models".
•	Subheading: Smaller text states: "Adjuvant could reduce need for frequent boosters with mRNA vaccines".
•	Metadata: Text below indicates the content is "Research", a "2 min read", and credited to "BOSTON CHILDREN'S COMMUNICATIONS".
•	Main Image: A digital, blue-toned illustration depicting microscopic, spherical SARS-CoV-2 virus particles covered in spike proteins.
•	Caption: A small black banner at the bottom left reads: "Artist rendition of SARS-CoV-2 particles. Image: petershreiber.media/iStock/Getty Images".</a></label><br><a href="https://mediacdn.aus.social/media_attachments/files/116/705/913/291/495/141/original/2cfde151ec463c34.png" rel="external">https://mediacdn.aus.social/media_attachments/files/116/705/913/291/495/141/original/2cfde151ec463c34.png</a></li><li><label><a rel="external" href="https://gnusocial.jp/attachment/6150729">Untitled attachment</a></label><br></li><li><article><header><div>Domain not in remote thumbnail source whitelist: media.springernature.com</div><h5><a href="https://www.nature.com/articles/s41590-026-02517-3?error=cookies_not_supported&amp;code=b0b4b4f3-37db-4e09-9a96-984208d5219d">A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines - Nature Immunology</a></h5><div> from <span>Zanoni, Ivan</span></div></header><div>Jena, Qu et al. show that mannadjuvant, a formulation of fungal mannan and aluminum hydroxide, increases the magnitude, durability and breadth of the response elicited by mRNA-based vaccines against SARS-CoV-2 variants in mice and non-human primates.</div><footer></footer></article></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Denis - The COVID info guy - (deniscovidinfoguy@aus.social)'s status on Sunday, 07-Jun-2026 09:41:02 JST Denis - The COVID info guy -
New Immune System Enhancer Extends COVID-19 Vaccine Protection In Animal Models.
"Pairing COVID-19 mRNA vaccines with an immune system enhancer, known as an adjuvant, could make the vaccines more effective and longer-lasting, according to new research led by Harvard Medical School researchers at Boston Children’s Hospital."
Source: https://hms.harvard.edu/news/new-immune-system-enhancer-extends-covid-19-vaccine-protection-animal-models
Study: https://www.nature.com/articles/s41590-026-02517-3
In conversationabout a month ago from aus.socialpermalink
Attachments
1. An image showing a research article webpage from Harvard Medical School, dated June 5, 2026. Layout and Content • Header: Displays the Harvard Medical School crest and logo at the top centre. • Headline: Large, bold white text on a dark grey background reads: "New Immune System Enhancer Extends COVID-19 Vaccine Protection In Animal Models". • Subheading: Smaller text states: "Adjuvant could reduce need for frequent boosters with mRNA vaccines". • Metadata: Text below indicates the content is "Research", a "2 min read", and credited to "BOSTON CHILDREN'S COMMUNICATIONS". • Main Image: A digital, blue-toned illustration depicting microscopic, spherical SARS-CoV-2 virus particles covered in spike proteins. • Caption: A small black banner at the bottom left reads: "Artist rendition of SARS-CoV-2 particles. Image: petershreiber.media/iStock/Getty Images".
  https://mediacdn.aus.social/media_attachments/files/116/705/913/291/495/141/original/2cfde151ec463c34.png
2. Untitled attachment
3. Domain not in remote thumbnail source whitelist: media.springernature.com
  A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines - Nature Immunology
  from Zanoni, Ivan
  Jena, Qu et al. show that mannadjuvant, a formulation of fungal mannan and aluminum hydroxide, increases the magnitude, durability and breadth of the response elicited by mRNA-based vaccines against SARS-CoV-2 variants in mice and non-human primates.

Public

Embed Notice

HTML Code

Corresponding Notice